You have 9 free searches left this month | for more free features.

Resistant Hypertension

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Heart Failure Preserved Ejection Fraction, Resistant Hypertension Trial in Birmingham (Allopurinol)

Not yet recruiting
  • Heart Failure Preserved Ejection Fraction
  • Resistant Hypertension
  • Birmingham, Alabama
    Birmingham VA Medical Center, Birmingham, AL
Jun 5, 2023

Hypertension Trial (Placebo, lorundrostat Dose 1, lorundrostat Dose 2)

Not yet recruiting
  • Hypertension
  • Placebo
  • +2 more
  • (no location specified)
Nov 22, 2023

Resistant Hypertension Trial (SAAE, traditional triple antihypertensive treatment)

Not yet recruiting
  • Resistant Hypertension
  • SAAE
  • traditional triple antihypertensive treatment
  • (no location specified)
Sep 20, 2022

End Stage Renal Disease, Hypertension, Renal Trial in Alexandria (L-Methyl Folate and methylcobalamine)

Recruiting
  • End Stage Renal Disease
  • Hypertension, Renal
  • L-Methyl Folate and methylcobalamine
  • Alexandria, Egypt
    Faculty of Pharmacy, Alexandria University
Mar 29, 2023

Resistant Hypertension Trial in Seoul (Spironolactone, Amiloride)

Recruiting
  • Resistant Hypertension
  • Seoul, Korea, Republic of
    Severance Cardiovascular Hospital, Yonsei University Health Syst
Jul 28, 2022

Systemic Microvascular Reactivity in Resistant Hypertension

Recruiting
  • Arterial Hypertension
  • +3 more
  • Evaluation of systemic skin microvascular endothelial function
  • Rio de Janeiro, Brazil
    Eduardo Tibiriçá
Jul 14, 2022

Resistant Hypertension Trial (RIC, Sham-RIC)

Not yet recruiting
  • Resistant Hypertension
  • RIC
  • Sham-RIC
  • (no location specified)
Jun 16, 2022

Resistant Hypertension Trial in Madrid (Moderate-intensity interval training (MIIT), Moderate-intensity continuous training

Recruiting
  • Resistant Hypertension
  • Moderate-intensity interval training (MIIT)
  • Moderate-intensity continuous training (MICT)
  • Madrid, Spain
    Universidad Europea Madrid (UEM)
Oct 5, 2022

The Long-term Safety and Effect of Renal Denervation

Recruiting
  • Hypertension
  • Renal denervation
  • London, Middlesex, United Kingdom
    Hammersmith Hospital
Apr 5, 2023

Hypertension (HTN) Trial in Manassas, Toronto (Firibastat (QGC001) Period 1)

Terminated
  • Hypertension (HTN)
  • Firibastat (QGC001) Period 1
  • Manassas, Virginia
  • +1 more
Jan 13, 2023

Fetuin A asPredictor of Deterioration of Renal Function in

Recruiting
  • Arterial Hypertension
  • No intervention.
  • Ostrava, Czech Republic, Czechia
    University Hospital Ostrava, - Department of Internal Medicine a
Jul 18, 2023

Coronary Microvascular Dysfunction, Resistant Hypertension, Hypertensive Heart Disease Trial (Invasive Physiological Assessment

Not yet recruiting
  • Coronary Microvascular Dysfunction
  • +2 more
  • Invasive Physiological Assessment of Coronary Circulation
  • (no location specified)
Aug 9, 2023

Primary Aldosteronism, Resistant Hypertension, Secondary Hypertension Trial in Boston (Best Practice Advisory Computerized

Not yet recruiting
  • Primary Aldosteronism
  • +5 more
  • Best Practice Advisory Computerized Alert
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jun 22, 2023

Resistant Hypertension Trial in Worldwide (BAT, Placebo)

Active, not recruiting
  • Resistant Hypertension
  • BAT
  • Placebo
  • Odense, Denmark
  • +4 more
Mar 14, 2022

Hypertension, Renal Trial in Hong Kong (Symplicity Spyral RENAL DENERVATION (RDN) SYSTEMTM Livewire™ Reflexion™ Catheter)

Recruiting
  • Hypertension, Renal
  • Symplicity Spyral RENAL DENERVATION (RDN) SYSTEMTM Livewire™ Reflexion™ Catheter
  • Hong Kong, Shatin, Hong Kong
  • +1 more
Feb 15, 2023

Resistant Hypertension Trial in Guangzhou (Sacubitril/valsartan, valsartan)

Recruiting
  • Resistant Hypertension
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Sep 16, 2022

Resistant Arterial Hypertension Trial in Ryazan (Blood samples will be taken for pharmacokinetics and pharmacogenetics)

Recruiting
  • Resistant Arterial Hypertension
  • Blood samples will be taken for pharmacokinetics and pharmacogenetics
  • Ryazan, Russian Federation
    Ryzan State Medical University
Jun 1, 2023

Resistant Hypertension Trial in Perth (Minocycline)

Recruiting
  • Resistant Hypertension
  • Perth, Western Australia, Australia
    Royal Perth Hospital
Sep 23, 2021

Resistant Hypertension Trial in Worldwide (Experimental drug, Placebo)

Recruiting
  • Resistant Hypertension
  • Experimental drug
  • Placebo
  • Guntersville, Alabama
  • +28 more
Jan 13, 2023

Hypertension Trial in Tomsk (Bilateral radiofrequency sympathetic renal denervation)

Completed
  • Hypertension
  • Bilateral radiofrequency sympathetic renal denervation
  • Tomsk, Russian Federation
    Institute of Cardiology, Siberian Branch of Russian Academy of M
Oct 4, 2021

Resistant Hypertension, Difficult to Control Hypertension Trial in United States (MANP, Placebo)

Recruiting
  • Resistant Hypertension
  • Difficult to Control Hypertension
  • Anniston, Alabama
  • +3 more
Mar 31, 2022

Sodium Intake, Resistant Hypertension Trial in Goyang (Sodium intake reduction, Exercise)

Terminated
  • Sodium Intake
  • Resistant Hypertension
  • Sodium intake reduction
  • Exercise
  • Goyang, Gyeonggi, Korea, Republic of
    Dongguk University Ilsan Hospital
Jul 7, 2021

Hypertension, Resistant to Conventional Therapy Trial in Tomsk (Distal renal denervation, Conventional renal denervation)

Completed
  • Hypertension, Resistant to Conventional Therapy
  • Distal renal denervation
  • Conventional renal denervation
  • Tomsk, Russian Federation
    Tomsk National Research Medical Center of the Russian Academy of
Oct 4, 2021

Treatment of Resistant Hypertension: Cohort Study

Recruiting
  • Resistant Hypertension
  • Add-on therapy
  • Belgrade, Serbia
  • +11 more
Oct 21, 2021

Treatment-Resistant Hypertension Trial in Durham (Structured center-based lifestyle intervention, Standard education and

Completed
  • Treatment-Resistant Hypertension
  • Structured center-based lifestyle intervention
  • Standard education and physician advice
  • Durham, North Carolina
    Duke University Medical Center
Mar 22, 2021